(CNN) — Several dozen patients with sickle cell disease will be among the first in the United States treated for a genetic disease with the experimental gene-editing technology CRISPR.
“This is an extraordinary time” in the treatment of sickle cell disease, said Dr. Alexis Thompson, hematology section head at the Ann and Robert H. Lurie Children’s Hospital of Chicago, who is not involved in the trial. “It’s terribly exciting that there is so much attention on cutting-edge science and a condition that has lagged far behind many other medically important diseases.”
https://edition-m.cnn.com/2019/07/30/health/crispr-trial-sickle-cell/index.html